Pearls and Pitfalls for the Emergency Clinician: Beta Blocker and Calcium Channel Blocker Toxicity

Beta blocker or calcium channel blocker toxicity is a serious condition that carries with it a high rate of morbidity and mortality.

This review highlights the pearls and pitfalls of beta blocker and calcium channel blocker toxicity, including presentation, diagnosis, and management in the emergency department (ED) based on current evidence.

Beta blocker and calcium channel blocker toxicity is a life-threatening emergency that requires prompt identification and management. Patients commonly present with both hypotension and bradycardia. The rare exception to this involves overdoses with dihydropyridines such as amlodipine which can initially present with hypotension and tachycardia before eventually developing bradycardia. Beta blockers such as propranolol can present with altered mentation, seizures, and ventricular dysrhythmias resulting from their ability to block sodium channels. Sotalol can cause significant QT prolongation in addition to hypotension and bradycardia. While laboratory evaluation does not confirm the diagnosis of beta blocker or calcium channel blocker toxicity, laboratory testing such as renal function and lactate can be used to evaluate for end organ perfusion, while acetaminophen, salicylate, and digoxin concentrations can be sent to evaluate for possible concomitant ingestions. Initial treatment should focus on fluids, atropine, calcium, and in select patients, gastrointestinal (GI) decontamination with activated charcoal. For more significant toxicity that does not respond to initial treatments, vasopressors and high-dose insulin should be considered, while intralipid and extracorporeal membrane oxygenation should be considered in the cases of refractory toxicity despite maximal therapy. Patients should be admitted to the intensive care unit for close hemodynamic monitoring.

An understanding of beta blocker and calcium channel blocker toxicity can assist emergency clinicians in diagnosing and managing this potentially deadly disease.